Effect of Adding a Biceps Femoris Short Head Block to Adductor Canal Block for Analgesia After Total Knee Arthroplasty (BiFeS-TKA)
Analgesic Efficacy of Adding a Short Head of the Biceps Femoris Muscle Block to the Adductor Canal Block in Total Knee Arthroplasty: A Prospective, Randomized, Controlled Trial
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
상세 설명
Background
Total knee arthroplasty (TKA) is the definitive surgical treatment for end-stage knee osteoarthritis and is one of the most frequently performed orthopedic procedures worldwide. Despite advances in multimodal analgesic strategies, postoperative pain following TKA remains a major clinical challenge. Inadequate pain control may delay early mobilization, impair functional recovery, prolong hospitalization, increase opioid consumption, and reduce patient satisfaction. Therefore, optimization of regional anesthesia techniques continues to be an important component of enhanced recovery protocols after TKA.
Ultrasound-guided adductor canal block (ACB) has become a widely accepted motor-sparing regional analgesic technique for TKA because it provides effective analgesia to the anteromedial aspect of the knee while largely preserving quadriceps muscle strength. Nevertheless, the posterior compartment of the knee receives sensory innervation from branches of the sciatic nerve that are not consistently anesthetized by ACB alone. Consequently, residual posterior knee pain remains a common limitation of this technique.
The ultrasound-guided biceps femoris short head (BiFeS) block is a recently described regional anesthesia technique that targets the posterolateral sensory innervation of the knee through deposition of local anesthetic within the fascial plane adjacent to the short head of the biceps femoris muscle. Anatomical and preliminary clinical investigations suggest that this technique may provide additional analgesic coverage of the posterior knee while preserving motor function. However, evidence regarding its clinical efficacy as an adjunct to ACB in patients undergoing primary TKA remains limited.
Study Objectives
The objective of this study is to determine whether the addition of an ultrasound-guided BiFeS block to a standard ultrasound-guided ACB provides superior postoperative analgesia compared with ultrasound-guided ACB alone in patients undergoing primary unilateral TKA under spinal anesthesia.
Study Design
This is a prospective, single-center, parallel-group, randomized controlled clinical trial. Eligible participants will be randomly assigned in a 1:1 ratio to receive either an ultrasound-guided adductor canal block or an ultrasound-guided adductor canal block combined with a biceps femoris short head block before surgery. All patients underwent total knee arthroplasty under single-shot spinal anesthesia with 15 mg of hyperbaric bupivacaine. No periarticular local infiltration analgesia was performed by the surgical team. Postoperatively, all patients received a standardized multimodal analgesic regimen consisting of intravenous paracetamol (1 g) administered every 8 hours. Rescue analgesia consisted of intravenous tramadol (100 mg), which was administered when the Numeric Rating Scale (NRS) pain score was ≥4.
Outcome Assessment
The primary endpoint is cumulative intravenous morphine consumption (mg) from arrival in the post-anesthesia care unit until 48 hours after surgery. Secondary endpoints include postoperative pain intensity assessed using the Numeric Rating Scale (NRS), time to first rescue analgesic administration, quadriceps muscle strength, functional recovery assessed by the Timed Up and Go test and knee range of motion, quality of postoperative recovery (QoR-15), postoperative nausea and vomiting, patient and surgeon satisfaction, length of hospital stay, and block-related adverse events.
Clinical Significance
This study is designed to provide high-quality evidence regarding the potential clinical benefit of incorporating the BiFeS block into contemporary multimodal analgesic protocols for total knee arthroplasty. If the combined regional analgesic approach demonstrates improved postoperative analgesia while preserving motor function, it may represent an effective strategy to facilitate enhanced recovery after surgery and reduce perioperative opioid requirements.
연구 유형
연구 유형
등록 (추정된)
등록
단계
단계
- 해당 없음
연락처 및 위치
연구 연락처
연구 연락처
- 이름: Nilgun Kavrut Ozturk, MD,Professor
- 전화번호: +905334196049
- 이메일: kavrut@yahoo.com
연구 연락처 백업
- 이름: Serhat Gulersen, MD,
- 전화번호: +905445336784
- 이메일: serhatgulersen@gmail.com
연구 장소
-
-
Antalya
-
Antalya, Antalya, 터키 (Türkiye), 07100
- Antalya Training and Research Hospital
-
연락하다:
- Nilgun Kavrut Ozturk, MD, Professor
- 전화번호: +95334196049
- 이메일: kavrut@yahoo.com
-
연락하다:
- Serhat Gulersen, MD
- 전화번호: +905445336784
- 이메일: serhatgulersen@gmail.com
-
수석 연구원:
- Serhat Gulersen, MD,
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
- Scheduled for elective primary unilateral total knee arthroplasty under spinal -anesthesia.
- American Society of Anesthesiologists (ASA) physical status I-III.
- Body mass index (BMI) <40 kg/m².
- Ability to understand the study procedures and provide written informed consent.
Exclusion Criteria:
- Refusal to participate or inability to provide informed consent.
- Body mass index 40 kg/m2 or higher.
- ASA physical status IV or V.
- Known allergy or hypersensitivity to local anesthetics, opioids, or other study -medications.
- Pregnancy or breastfeeding.
- Uncontrolled psychiatric disease or severe anxiety interfering with study participation.
- Pre-existing neuromuscular disease or peripheral neuropathy involving the operative limb.
- Chronic opioid use or opioid dependence.
- Chronic pain syndrome requiring regular analgesic therapy.
- Severe hepatic or renal insufficiency.
- Contraindications to spinal anesthesia or peripheral nerve block, including -coagulopathy, thrombocytopenia, local infection at the injection site, or patient refusal.
- Planned bilateral or revision total knee arthroplasty.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 더블
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
활성 비교기: Ultrasound-Guided Adductor Canal Block
Participants assigned to this arm will receive an ultrasound-guided adductor canal block before the induction of spinal anesthesia for primary unilateral total knee arthroplasty.
All regional blocks will be performed according to a standardized study protocol.
Perioperative anesthetic management, surgical procedures, and postoperative multimodal analgesia will be standardized for all participants.
|
An ultrasound-guided adductor canal block will be performed before the induction of spinal anesthesia using a standardized technique.
Following ultrasound identification of the adductor canal, 30 mL of 0.25% bupivacaine will be injected into the adductor canal adjacent to the femoral artery to provide perioperative analgesia for primary unilateral total knee arthroplasty.
|
|
실험적: Ultrasound-Guided Adductor Canal Block Combined With Biceps Femoris Short Head Block
Participants assigned to this arm will receive an ultrasound-guided adductor canal block combined with an ultrasound-guided biceps femoris short head block before spinal anesthesia for primary unilateral total knee arthroplasty.
Both regional blocks will be performed according to a standardized study protocol.
Perioperative anesthetic management, surgical procedures, and postoperative multimodal analgesic regimens will be standardized for all participants.
|
An ultrasound-guided adductor canal block will be performed before the induction of spinal anesthesia using a standardized technique.
Following ultrasound identification of the adductor canal, 30 mL of 0.25% bupivacaine will be injected into the adductor canal adjacent to the femoral artery to provide perioperative analgesia for primary unilateral total knee arthroplasty.
An ultrasound-guided biceps femoris short head block will be performed before the induction of spinal anesthesia using a standardized technique.
Following ultrasound identification of the fascial plane adjacent to the short head of the biceps femoris muscle, 20 mL of 0.25% bupivacaine will be administered to provide additional posterolateral knee analgesia as an adjunct to the adductor canal block.
|
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Cumulative Opioid Consumption
기간: From arrival in the post-anesthesia care unit until 48 hours after surgery
|
Cumulative opioid consumption during the first 48 postoperative hours, recorded as intravenous morphine equivalent dose (mg).
|
From arrival in the post-anesthesia care unit until 48 hours after surgery
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Postoperative Pain Intensity
기간: 4, 8, 12, 24, and 48 hours after surgery
|
Postoperative pain intensity will be assessed using the 11-point Numeric Rating Scale (NRS).
Scores range from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
Pain will be evaluated both at rest and during knee flexion.
Lower scores indicate better postoperative analgesia.
|
4, 8, 12, 24, and 48 hours after surgery
|
|
Time to First Rescue Analgesic Administration
기간: During the first 48 postoperative hours
|
Time from completion of surgery to the first administration of rescue analgesic medication, recorded in hours.
Longer time intervals indicate prolonged postoperative analgesic effectiveness.
|
During the first 48 postoperative hours
|
|
Quadriceps Muscle Strength
기간: Preoperatively and at 8, 24, and 48 hours after surgery
|
Quadriceps muscle strength will be assessed using the Manual Muscle Testing (MMT) Scale, ranging from 0 to 5, where 0 represents no visible muscle contraction and 5 represents normal muscle strength against full resistance.
Higher scores indicate greater quadriceps muscle strength.
|
Preoperatively and at 8, 24, and 48 hours after surgery
|
|
Functional Mobility
기간: 24 and 48 hours after surgery
|
Functional mobility will be evaluated using the Timed Up and Go (TUG) Test.
The total time (seconds) required to stand from a seated position, walk 3 meters, turn, return, and sit down will be recorded.
Shorter completion times indicate better functional mobility.
Participants who were unable to perform the TUG test independently at 24 hours after surgery were withdrawn from the study according to the study protocol.
|
24 and 48 hours after surgery
|
|
Knee Range of Motion
기간: Preoperatively and at 12 and 24 hours after surgery
|
Active knee flexion range of motion will be measured in the supine position using a standard goniometer.
The maximum active knee flexion angle will be recorded in degrees.
|
Preoperatively and at 12 and 24 hours after surgery
|
|
Quality of Recovery at 24 Hours Assessed Using QoR-15
기간: 24 hours after surgery
|
Recovery quality will be evaluated using the Quality of Recovery-15 (QoR-15) questionnaire.
Total scores range from 0 to 150, with higher scores indicating better postoperative recovery.
|
24 hours after surgery
|
|
Postoperative Nausea and Vomiting
기간: Incidence of postopereative nausea and/ or vomiting within 48 hours
|
The severity of postoperative nausea and vomiting will be assessed using a 4-point ordinal scale (0-3), where 0 = none, 1 = mild, 2 = moderate, and 3 = severe.
Lower scores indicate fewer postoperative symptoms.
|
Incidence of postopereative nausea and/ or vomiting within 48 hours
|
|
Patient Satisfaction
기간: 48 hours after surgery
|
Patient satisfaction with postoperative pain management will be assessed using a 5-point Likert scale, ranging from 1 (very dissatisfied) to 5 (very satisfied).
Higher scores indicate greater patient satisfaction.
|
48 hours after surgery
|
|
Surgeon Satisfaction
기간: At completion of surgery
|
Surgeon satisfaction with perioperative conditions will be assessed using a 5-point Likert scale, ranging from 1 (very dissatisfied) to 5 (very satisfied).
Higher scores indicate greater surgeon satisfaction.
|
At completion of surgery
|
|
Length of Hospital Stay
기간: From end of surgery to hospital discharge, assessed up to 10 days
|
Length of hospital stay will be defined as the time from completion of surgery until hospital discharge and will be recorded in hours.
Shorter hospital stay indicates earlier postoperative recovery.
|
From end of surgery to hospital discharge, assessed up to 10 days
|
|
Block-Related Adverse Events
기간: From block placement to hospital discharge, assessed up to 10 days
|
The incidence of block-related adverse events, including neurological injury, foot drop, local anesthetic systemic toxicity, hematoma, infection, allergic reactions, and myotoxicity, will be recorded.
Outcomes will be reported as the number of participants experiencing each event.
|
From block placement to hospital discharge, assessed up to 10 days
|
공동 작업자 및 조사자
수사관
수사관
- 수석 연구원: Serhat Gulersen, MD,, University of Health Sciences Türkiye, Antalya Training and Research Hospital
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
기타 연구 ID 번호
- 10840098-202.3.02-446
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .